Camp4 Therapeutics (CAMP) Research & Development (2023 - 2026)

Camp4 Therapeutics (CAMP) has 4 years of Research & Development data on file, last reported at $10.2 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development changed 0.14% year-over-year to $10.2 million; the trailing twelve-month figure through Mar 2026 stood at $214000.0 (down 99.45% YoY), and the FY2025 full-year result was $200000.0, down 99.48% from the prior year.
• Research & Development improved to $10.2 million in Q1 2026, from -$29.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $10.7 million in Q4 2023 to a low of -$29.6 million in Q4 2025.
• A 4-year average of $6.3 million and a median of $9.8 million in 2023 frame the typical range for Research & Development.
• Peak annual rise in Research & Development reached 10.16% in 2025, while the deepest fall reached 396.57% in 2025.
• Tracing CAMP's Research & Development over 4 years: stood at $10.7 million in 2023, then slipped by 6.24% to $10.0 million in 2024, then tumbled by 396.57% to -$29.6 million in 2025, then jumped by 134.27% to $10.2 million in 2026.
• Business Quant data shows CAMP's Research & Development at $10.2 million in Q1 2026, -$29.6 million in Q4 2025, and $9.4 million in Q3 2025.